|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-3-30
|
|
pubmed:abstractText |
Accelerated schedules are effective in overcoming repopulation during radiotherapy (RT) for head-and-neck cancers, but their feasibility is compromised by increased toxicity. The therapeutic ratio may be particularly favorable for 5-week regimens. This study reports the 10-year experience of a single institution in the routine use of concomitant boost RT as standard radical treatment in all but the most favorable stage patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1431-6
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15050320-Adolescent,
pubmed-meshheading:15050320-Adult,
pubmed-meshheading:15050320-Aged,
pubmed-meshheading:15050320-Aged, 80 and over,
pubmed-meshheading:15050320-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15050320-Carcinoma, Squamous Cell,
pubmed-meshheading:15050320-Cause of Death,
pubmed-meshheading:15050320-Cisplatin,
pubmed-meshheading:15050320-Combined Modality Therapy,
pubmed-meshheading:15050320-Dose Fractionation,
pubmed-meshheading:15050320-Feasibility Studies,
pubmed-meshheading:15050320-Female,
pubmed-meshheading:15050320-Fluorouracil,
pubmed-meshheading:15050320-Head and Neck Neoplasms,
pubmed-meshheading:15050320-Humans,
pubmed-meshheading:15050320-Male,
pubmed-meshheading:15050320-Middle Aged,
pubmed-meshheading:15050320-Statistics as Topic
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience.
|
|
pubmed:affiliation |
Division of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland. abdelkarim.alla1@hcuge.ch
|
|
pubmed:publicationType |
Journal Article
|
